• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在脓毒症和急性肾损伤患者中使用高通量血液滤过器进行连续静脉-静脉血液透析时降钙素原和选定细胞因子的清除。

Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.

机构信息

Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, Warsaw, Poland.

Department of Laboratory Diagnostics, Military Institute of Medicine, Warsaw, Poland.

出版信息

Blood Purif. 2018;46(2):153-159. doi: 10.1159/000488929. Epub 2018 Apr 27.

DOI:10.1159/000488929
PMID:29705804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6008874/
Abstract

INTRODUCTION

The purpose of this study was to evaluate the impact of continuous veno-venous hemodialysis (CVVHD) using high cutoff (HCO) hemofilters on the removal of procalcitonin (PCT), and other inflammatory markers in the treatment of patients during septic shock with acute kidney injury (AKI).

MATERIALS AND METHODS

Thirty-six patients with septic shock and AKI were included in the study. Before and after the 24-h HCO-CVVHD, PCT, native C-reactive protein (CRP) and cytokines (interleukin-1β, interleukin-6, interleukin-12, interleukin-17, tumor necrosis factor-α) in serum and effluent were assessed.

RESULTS

After the HCO-CVVHD serum concentrations of PCT, CRP and selected cytokines were significantly lower. The decrease in PCT was bigger than in CRP (p = 0.007). The change in PCT concentration was significantly influenced by PCT and IL-17 clearances (R2 = 0.525; p < 0.001).

CONCLUSION

In contrast to the native CRP, monitoring of PCT during HCO-CVVHD is less useful because it reflects the clearance of this marker and anti-inflammatory effectiveness of the method.

摘要

简介

本研究旨在评估使用高通量(HCO)血液滤器进行连续静脉-静脉血液透析(CVVHD)对脓毒性休克合并急性肾损伤(AKI)患者治疗中降钙素原(PCT)和其他炎症标志物清除的影响。

材料和方法

本研究纳入了 36 例脓毒性休克合并 AKI 患者。在 24 小时 HCO-CVVHD 前后,评估了血清和流出液中 PCT、天然 C 反应蛋白(CRP)和细胞因子(白细胞介素-1β、白细胞介素-6、白细胞介素-12、白细胞介素-17、肿瘤坏死因子-α)的水平。

结果

HCO-CVVHD 后,血清 PCT、CRP 和选定细胞因子的浓度显著降低。与 CRP 相比,PCT 的下降幅度更大(p = 0.007)。PCT 浓度的变化与 PCT 和 IL-17 的清除率显著相关(R2 = 0.525;p < 0.001)。

结论

与天然 CRP 相比,在 HCO-CVVHD 期间监测 PCT 的意义不大,因为它反映了该标志物的清除率和方法的抗炎效果。

相似文献

1
Removal of Procalcitonin and Selected Cytokines during Continuous Veno-Venous Hemodialysis Using High Cutoff Hemofilters in Patients with Sepsis and Acute Kidney Injury.在脓毒症和急性肾损伤患者中使用高通量血液滤过器进行连续静脉-静脉血液透析时降钙素原和选定细胞因子的清除。
Blood Purif. 2018;46(2):153-159. doi: 10.1159/000488929. Epub 2018 Apr 27.
2
Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.高截留量血液滤过器对伴有急性肾损伤的感染性休克患者特定细胞因子的清除效果——初步研究
Med Sci Monit. 2016 Nov 13;22:4338-4344. doi: 10.12659/MSM.896819.
3
Clearance of Selected Plasma Cytokines with Continuous Veno-Venous Hemodialysis Using Ultraflux EMiC2 versus Ultraflux AV1000S.使用 Ultraflux EMiC2 与 Ultraflux AV1000S 行连续静-静脉血液透析清除选定的血浆细胞因子。
Blood Purif. 2017;44(4):260-266. doi: 10.1159/000478965. Epub 2017 Oct 7.
4
Organ dysfunction during continuous veno-venous high cut-off hemodialysis in patients with septic acute kidney injury: A prospective observational study.脓毒症急性肾损伤患者持续静脉-静脉高通量血液透析期间的器官功能障碍:一项前瞻性观察研究。
PLoS One. 2017 Feb 16;12(2):e0172039. doi: 10.1371/journal.pone.0172039. eCollection 2017.
5
Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients.持续静脉-静脉血液滤过联合透析可清除脓毒症患者循环中的细胞因子。
Crit Care Med. 1993 Apr;21(4):522-6. doi: 10.1097/00003246-199304000-00011.
6
Clearance of inflammatory cytokines in patients with septic acute kidney injury during renal replacement therapy using the EMiC2 filter (Clic-AKI study).在使用 EMiC2 过滤器进行肾脏替代治疗时,清除脓毒症急性肾损伤患者的炎症细胞因子(Clic-AKI 研究)。
Crit Care. 2021 Jan 28;25(1):39. doi: 10.1186/s13054-021-03476-x.
7
Clearance of NT-proBNP and Procalcitonin during Continuous Venovenous Hemodialysis with the Medium Cutoff Filter in Patients with Rhabdomyolysis-Associated Early Acute Kidney Injury.横纹肌溶解症相关早期急性肾损伤患者应用中分子截留滤器行连续性静脉-静脉血液透析时 NT-proBNP 和降钙素原的清除率。
Blood Purif. 2023;52(5):446-454. doi: 10.1159/000528861. Epub 2023 Mar 7.
8
Clearance of myoglobin by high cutoff continuous veno-venous hemodialysis in a patient with rhabdomyolysis: a case report.高截留量持续静静脉血液透析清除横纹肌溶解症患者肌红蛋白:一例报告
Hemodial Int. 2015 Jan;19(1):135-40. doi: 10.1111/hdi.12172. Epub 2014 Apr 27.
9
Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with "high cut-off" membranes (HCO-CVVHDF)?
Clin Chem Lab Med. 2013 Jun 21;51(11):e261-3. doi: 10.1515/cclm-2013-0257.
10
Effects of Changes in the Levels of Damage-Associated Molecular Patterns Following Continuous Veno-Venous Hemofiltration Therapy on Outcomes in Acute Kidney Injury Patients With Sepsis.连续性静脉-静脉血液滤过治疗后损伤相关分子模式水平变化对脓毒症急性肾损伤患者结局的影响。
Front Immunol. 2019 Jan 7;9:3052. doi: 10.3389/fimmu.2018.03052. eCollection 2018.

引用本文的文献

1
Procalcitonin levels in septic and nonseptic subjects with AKI and ESKD prior to and during continuous kidney replacement therapy (CKRT).在接受连续性肾脏替代治疗(CKRT)之前及期间,患有急性肾损伤(AKI)和终末期肾病(ESKD)的脓毒症和非脓毒症患者的降钙素原水平。
Crit Care. 2025 Apr 30;29(1):171. doi: 10.1186/s13054-025-05414-7.
2
Evaluation of continuous blood purification in patients with urosepsis caused by ureteral calculi and heart failure after catheterization.输尿管结石致尿脓毒症并导尿后心力衰竭患者的连续性血液净化评估
Pak J Med Sci. 2024 May-Jun;40(5):1030-1034. doi: 10.12669/pjms.40.5.8386.
3
Predictive values of the SOFA score and procalcitonin for septic shock after percutaneous nephrolithotomy.SOFA 评分和降钙素原对经皮肾镜取石术后脓毒性休克的预测价值。
Urolithiasis. 2022 Dec;50(6):729-735. doi: 10.1007/s00240-022-01366-7. Epub 2022 Oct 10.
4
Prognostic significance of PCT and CRP evaluation for adult ICU patients with sepsis and septic shock: retrospective analysis of 59 cases.降钙素原和C反应蛋白评估对成人脓毒症和脓毒性休克重症监护病房患者的预后意义:59例回顾性分析
J Int Med Res. 2019 Apr;47(4):1573-1579. doi: 10.1177/0300060518822404. Epub 2019 Jan 18.

本文引用的文献

1
Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy.降钙素原:一种用于脓毒症和抗生素治疗的有前景的诊断标志物。
J Intensive Care. 2017 Aug 3;5:51. doi: 10.1186/s40560-017-0246-8. eCollection 2017.
2
Diagnostic accuracy of procalcitonin, neutrophil-lymphocyte count ratio, C-reactive protein, and lactate in patients with suspected bacterial sepsis.降钙素原、中性粒细胞与淋巴细胞计数比值、C反应蛋白及乳酸在疑似细菌性脓毒症患者中的诊断准确性
PLoS One. 2017 Jul 20;12(7):e0181704. doi: 10.1371/journal.pone.0181704. eCollection 2017.
3
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016.拯救脓毒症运动:脓毒症与脓毒性休克管理国际指南:2016版
Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
4
Effectiveness of High Cut-Off Hemofilters in the Removal of Selected Cytokines in Patients During Septic Shock Accompanied by Acute Kidney Injury-Preliminary Study.高截留量血液滤过器对伴有急性肾损伤的感染性休克患者特定细胞因子的清除效果——初步研究
Med Sci Monit. 2016 Nov 13;22:4338-4344. doi: 10.12659/MSM.896819.
5
Nomenclature for renal replacement therapy in acute kidney injury: basic principles.急性肾损伤中肾脏替代治疗的命名:基本原则
Crit Care. 2016 Oct 10;20(1):318. doi: 10.1186/s13054-016-1489-9.
6
Effect of interleukin-17 on in vitro cytokine production in healthy controls and patients with severe sepsis.白细胞介素-17对健康对照者和严重脓毒症患者体外细胞因子产生的影响。
J Formos Med Assoc. 2015 Dec;114(12):1250-7. doi: 10.1016/j.jfma.2014.09.009. Epub 2015 Jan 28.
7
Cytokine removal with high cut-off membrane: review of literature.
Blood Purif. 2014;38(3-4):167-73. doi: 10.1159/000369155. Epub 2014 Dec 3.
8
Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.五聚体 C 反应蛋白单体解离导致炎症局部化和加重:强有力的促炎机制的体内证据和一种新的抗炎策略。
Circulation. 2014 Jul 1;130(1):35-50. doi: 10.1161/CIRCULATIONAHA.113.007124. Epub 2014 Apr 28.
9
Combined extracorporeal therapy for severe sepsis in patients after cardiac surgery.心脏手术后严重脓毒症患者的联合体外治疗。
Blood Purif. 2014;37(1):39-46. doi: 10.1159/000357015. Epub 2014 Feb 5.
10
Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with "high cut-off" membranes (HCO-CVVHDF)?
Clin Chem Lab Med. 2013 Jun 21;51(11):e261-3. doi: 10.1515/cclm-2013-0257.